Heart failure : a companion to Braunwald's heart disease

著者

書誌事項

Heart failure : a companion to Braunwald's heart disease

[edited by] Douglas L. Mann, G. Michael Felker

Elsevier, c2016

3rd ed

大学図書館所蔵 件 / 8

この図書・雑誌をさがす

注記

Complemented by: Braunwald's heart disease / edited by Douglas L. Mann ... [et al.]. 10th ed. c2015

Includes bibliographical references and index

内容説明・目次

内容説明

Lead editor of Braunwald's Heart Disease, Dr. Douglas L. Mann, and nationally and internationally recognized heart failure expert Dr. G. Michael Felker, bring you the latest, definitive state-of-the art information on heart failure in this outstanding Braunwald's companion volume. Heart Failure, 3rd Edition, keeps you current with recent developments in the field, improved patient management strategies, and new drug therapies and implantable devices that will make a difference in your patients' lives and in your practice. Braunwald's Heart Failure Companion also has an on-line version that is updated with late-breaking clinical trials, "Hot Off the Press" commentary and Focused Reviews that are relevant to heart failure. "Heart Failure will be of enormous interest and value to clinicians, investigators, and trainees who are concerned with enriching their understanding of and caring for the ever growing number of patients with this condition. We are proud of this important companion to Heart Disease: A Textbook of Cardiovascular Medicine." Foreword by: Eugene Braunwald, Douglas P. Zipes, Peter Libby and Robert O. Bonow, Feb 2015 Consult this title on your favorite e-reader, conduct rapid searches, and adjust font sizes for optimal readability. Compatible with Kindle , nook , and other popular devices. Use this Braunwald's companion as the definitive source to prepare for the ABIM's new Heart Failure board exam. Access the fully searchable contents of the book online at expertconsult.com. This edition includes 67 new authors, who are experts in the field of heart failure Stay on the cutting edge with new chapters on: The latest practice guidelines for medical and device therapy Hemodynamic assessment of heart failure Contemporary medical therapy for heart failure patients with reduced and preserved ejection fraction Biomarkers in heart failure Pulmonary hypertension Management of co-morbidities in heart failure Mechanical cardiac support devices Get up to speed with the latest clinical trials, as well as how they have influenced current practice guidelines Explore what's changing in key areas such as basic mechanisms of heart failure, genetic screening, cell and gene therapies, pulmonary hypertension, heart failure prevention, co-morbid conditions, telemedicine/remote monitoring, and palliative care

目次

Section 1. Basic Mechanisms of Heart Failure 1. Molecular Basis for Heart Failure 2. Cellular Basis for Heart Failure 3. Cellular Basis for Myocardial Regeneration and Repair 4. Myocardial Basis for Heart Failure: Role of Cardiac Interstitium Section 2. Mechanisms of Disease Progression in Heart Failure 5. Molecular Signaling Mechanisms of the Renin-Angiotensin System in Heart Failure 6. Adrenergic Receptor Signaling in Heart Failure 7. Role of Innate Immunity in Heart Failure 8. Oxidative Stress in Heart Failure 9. Alterations in Ventricular Function in Systolic Heart Failure 10. Alterations in Ventricular Function: Diastolic Heart Failure 11. Alterations in Ventricular Structure: Role of Left Ventricular Remodeling and Reverse Remodeling in Heart Failure 12. Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure 13. Alterations in the Peripheral Circulation in Heart Failure 14. Alterations in Kidney Function Associated with Heart Failure 15. Alterations in Skeletal Muscle in Heart Failure 16. Alterations in Cardiac Metabolism Section 3. Etiological Basis for Heart Failure 17. Epidemiology of Heart Failure 18. Heart Failure as a Consequence of Ischemic Heart Disease 19. Heart Failure as a Consequence of Dilated Cardiomyopathy 20. The Restrictive and Infiltrative Cardiomyopathies and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy 21. Heart Failure As A Consequence of Hypertrophic Cardiomyopathy 22. Heart Failure as a Consequence of Genetic Cardiomyopathy 23. Heart Failure as a Consequence of Hypertension 24. Heart Failure As A Consequence of Valvular Heart Disease 25. Heart Failure as a Consequence of Congenital Heart Disease 26. Heart Failure as a Consequence of Viral and Non-viral Myocarditis 27. Heart Failure in the Developing World Section 4. Clinical Assessment of Heart Failure 28. Clinical Evaluation of Heart Failure 29. Cardiac Imaging In Heart Failure 30. The Use of Biomarkers in the Evaluation of Patients with Heart Failure 31. Hemodynamics in Heart Failure Section 5. Therapy for Heart Failure 32. Disease Prevention in Heart Failure 33. Management of Acute Decompensated Heart Failure 34. Contemporary Medical Therapy for Heart Failure Patients With Reduced Ejection Fraction 35. Management of Arrhythmias and Device Therapy in Heart Failure 36. Treatment of Heart Failure with Preserved Ejection Fraction 37. Management of Heart Failure in Special Populations: Older Patients, Women, and Racial/Ethnic Minority Groups 38. Stem Cell-Based and Gene Therapies in Heart Failure 39. Pulmonary Hypertension 40. Cardiac Transplantation 41. Surgical Treatment of Chronic Congestive Heart Failure 42. Circulatory Assist Devices in Heart Failure 43. Managing Heart Failure in Cancer Patients 44. Disease Management in Heart Failure 45. Management of Comorbidities in Heart Failure for the third edition of Heart Failure 46. Measuring Quality Outcomes in Heart Failure 47. Decision Making and Palliative Care in Advanced Heart Failure

「Nielsen BookData」 より

詳細情報

  • NII書誌ID(NCID)
    BB2036922X
  • ISBN
    • 9781455772377
  • LCCN
    2014039592
  • 出版国コード
    us
  • タイトル言語コード
    eng
  • 本文言語コード
    eng
  • 出版地
    Philadelphia, PA
  • ページ数/冊数
    xxi, 762 p.
  • 大きさ
    29 cm
  • 分類
  • 件名
ページトップへ